ArticleJournal of translational autoimmunity2026
Distinct risk factors for thrombosis in systemic lupus erythematosus and primary Sjögren's syndrome: A large Chinese cohort study with arterial-venous distinction.
Article in Journal of translational autoimmunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to compare the overall incidence and arterial-venous distribution of thrombosis, identify independent predictors of total and subtype-specific events, develop a prediction model, and evaluate the discriminative performance of risk factors in systemic lupus erythematosus (SLE) and primary Sjögren's syndrome (pSS). Methods: This retrospective study included 955 SLE patients and 558 pSS patients from a single center. Cox proportional hazards regression was used to determine independent risk factors for thrombosis. Discriminative ability was assessed using the time-dependent area under the curve (AUC) and Harrell's concordance index (C-index). Results: Median follow-up was 10 years (interquartile range [IQR] 8-12) for SLE and 9 years (IQR 7-12) for pSS. In multivariable analysis, independent risk factors for total thrombosis in SLE were hypertension (hazard ratio [HR] 1.523, 95% confidence interval [CI] 1.213-2.135, Conclusion: The underlying risk-factor profiles differ fundamentally between SLE and pSS. The SLE prediction model demonstrates acceptable-good discriminative performance and may serve as a guide for thrombotic risk stratification. Routine LA screening, alongside standardized management of modifiable cardiovascular risk factors, should be incorporated into long-term thromboprophylaxis strategies for both diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.